Prof. Dr. Güliz ERDEM

1. Systematic review and meta-analysis of randomized controlled trials on safety and effectiveness of oral anticoagulants for atrial fibrillation in older people.

Erdem G., EŞME M., DOĞU B. B.

Irish journal of medical science , cilt.191, sa.6, ss.2517-2523, 2022 (SCI-Expanded, Scopus)

2. Is heart failure an obstacle to air travel?

Erdem G.

Anatolian journal of cardiology , cilt.25, sa.Suppl 1, ss.10-12, 2021 (SCI-Expanded, Scopus, TRDizin)

3. Aortic valve function post-replacement of severe aortic stenosis by transcatheter procedure versus surgery: a systematic review and metanalysis.

Abi Khalil C., Ignatiuk B., Erdem G., Chemaitelly H., Barilli F., El-Shazly M., et al.

Scientific reports , cilt.11, sa.1, ss.11975, 2021 (SCI-Expanded, Scopus)

4. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

Mullen M., Jin X. Y., Child A., Stuart A. G., Dodd M., Aragon-Martin J. A., et al.

The Lancet , cilt.394, sa.10216, ss.2263-2270, 2019 (SCI-Expanded, Scopus)

5. Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration

Pitcher A., Emberson J., Lacro R. V., Sleeper L. A., Stylianou M., Mahony L., et al.

American Heart Journal , cilt.169, sa.5, ss.605-612, 2015 (SCI-Expanded, Scopus)

6. A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): Study protocol

Mullen M. J., Flather M. D., Jin X. Y., Newman W. G., Erdem G., Gaze D., et al.

Trials , cilt.14, sa.1, 2013 (SCI-Expanded, Scopus)

7. Rates and causes of death from non-ST elevation acute coronary syndromes: Ten year follow-up of the PRAIS-UK registry

Erdem G., Bakhai A., Taneja A. K., Collinson J., Banya W., Flather M. D.

International Journal of Cardiology , cilt.168, sa.1, ss.490-494, 2013 (SCI-Expanded, Scopus)

8. Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design.

Kotecha D., Manzano L., Altman D. G., Krum H., Erdem G., Williams N., et al.

Systematic reviews , cilt.2, ss.7, 2013 (Scopus)

9. How should I treat an ostial thrombotic occlusion of the right coronary artery in the setting of an acute myocardial infarction?

Izgi C., Feray H., Erdem G., Bakal R. B.

EuroIntervention , cilt.8, sa.2, 2012 (SCI-Expanded, Scopus)

10. Assessing bleeding risk in acute coronary syndromes Evaluación del riesgo de hemorragia en los síndromes coronarios agudos

Erdem G., Flather M.

Revista Espanola de Cardiologia , cilt.65, sa.1, ss.4-6, 2012 (SCI-Expanded, Scopus)

11. What goes into a major acute coronary syndrome trial and what will future trials look like?

Erdem G., Geisler T., Flather M. D.

Current Cardiology Reports , cilt.12, sa.4, ss.348-355, 2010 (Scopus)

12. Effect of Metoprolol on Heart Rate Variability in Symptomatic Patients With Mitral Valve Prolapse

TAÇOY G., Balcioǧlu A. S., Arslan U., Durakoǧlugil E., Erdem G., ÖZDEMİR H. M., et al.

American Journal of Cardiology , cilt.99, sa.11, ss.1568-1570, 2007 (SCI-Expanded, Scopus)

13. Head-to-head comparison of two different low-molecular-weight heparins in acute coronary syndrome. A single center experience

ÖZDEMİR H. M., Erdem G., TÜRKOĞLU S., CEMRİ M., Timurkaynak T., Boyaci B., et al.

Japanese Heart Journal , cilt.43, sa.5, ss.433-442, 2002 (SCI-Expanded, Scopus)

14. Sidebranch occlusion after coronary stenting with or without balloon predilation: direct versus conventional stenting.

Timurkaynak T., Ciftci H., Ozdemir M., Cengel A., Tavil Y., Kaya M., et al.

The Journal of invasive cardiology , cilt.14, sa.9, ss.497-501, 2002 (Scopus)

15. Myocardial injury after apparently successful coronary stenting with or without balloon dilation: direct versus conventional stenting.

Timurkaynak T., Ozdemir M., Cengel A., Ciftci H., Cemri M., Erdem G., et al.

The Journal of invasive cardiology , cilt.14, sa.4, ss.167-70, 2002 (Scopus)

Prof. Dr. Güliz ERDEM

Yayınlar & Eserler

1. Systematic review and meta-analysis of randomized controlled trials on safety and effectiveness of oral anticoagulants for atrial fibrillation in older people.

2. Is heart failure an obstacle to air travel?

3. Aortic valve function post-replacement of severe aortic stenosis by transcatheter procedure versus surgery: a systematic review and metanalysis.

4. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

5. Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration

6. A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): Study protocol

7. Rates and causes of death from non-ST elevation acute coronary syndromes: Ten year follow-up of the PRAIS-UK registry

8. Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design.

9. How should I treat an ostial thrombotic occlusion of the right coronary artery in the setting of an acute myocardial infarction?

10. Assessing bleeding risk in acute coronary syndromes Evaluación del riesgo de hemorragia en los síndromes coronarios agudos

11. What goes into a major acute coronary syndrome trial and what will future trials look like?

12. Effect of Metoprolol on Heart Rate Variability in Symptomatic Patients With Mitral Valve Prolapse

13. Head-to-head comparison of two different low-molecular-weight heparins in acute coronary syndrome. A single center experience

14. Sidebranch occlusion after coronary stenting with or without balloon predilation: direct versus conventional stenting.

15. Myocardial injury after apparently successful coronary stenting with or without balloon dilation: direct versus conventional stenting.

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Açık Erişim